XML 42 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 15 - Concentrations and Credit Risk
6 Months Ended
Oct. 31, 2014
Note 15 - Concentrations and Credit Risk:  
Note 15 - Concentrations and Credit Risk

NOTE 15 - CONCENTRATIONS AND CREDIT RISK

 

(i)    Customer Concentrations

 

The top customer concentrations, which the sales income is over 10% of total sales for the six months ended October 31, 2014 and 2013 are as follows:

   

 

 

Net Sales

 

For the six months ended October 31, 2014

For the six months ended October 31, 2013

 

Chinese Medicine

Stevioside

Chinese Medicine

Stevioside

Qufu Shengwang Import and Export Trade Co., Ltd*

                            -

                    31.6%

                             -  

                  44.2%

Qingdao Runde Biological Technology Co.Ltd

                            -

                    13.0%

                             -  

                  13.6%

Zhonghua (Qingdao) Industrial Co., Ltd.

                            -

                    20.7%

                             -  

                          -  

Guangdong Tengjun Veterinary Medicine Co., Ltd

                            -

                             -  

                    12.5%

                          -  

Total

                            -

                    65.3%

                    12.5%

                  57.8%

   

 

 * Qufu Shengwang Import and Export Trade Co., Ltd is a related party, which is controlled by Mr. Laiwang Zhang,  President, Chairman and a principal shareholder of our company.

 

  (ii)    Vendor Concentrations

 

The top vendor concentrations, which the purchase from those vendor is over 10% of total cost of goods sold, for the six months ended October 31, 2014 and 2013 are as follows:

  

 

 

Net Purchases

 

For the six months ended October 31, 2014

For the six months ended October 31, 2013

 

Chinese Medicine

Stevioside

Chinese Medicine

Stevioside

Shandong Heze Zhongshun Pharmaceutical Co., Ltd

                          -  

                             -  

                  19.6%

                       -  

Bozhou Weitao Pharmaceutical Co., Ltd

                          -  

                             -  

                  13.8%

                       -  

Qufu Longheng Materials Co., Ltd

                          -  

                             -  

                  21.3%

                       -  

Gansu Fanzhi Biology Techonology Co.,Ltd

                    9.4%

                             -  

                  15.9%

                       -  

Gansu DunHuang Agriculture Products Co.,Ltd

                          -  

                             -  

                          -  

               10.9%

Gansu Puhua Stevia Develop Co., Ltd

                          -  

                    25.4%

                          -  

                       -  

Shandong Jinhuaxia Environment Engineering Co. Ltd.

                          -  

                             -  

                          -  

               12.2%

Mingguang Xingshi Stevia Corp.

                          -  

                    15.8%

                          -  

                       -  

Ganzhou Julong High Tech Co., Ltd

                          -  

                    15.9%

                          -  

                       -  

Total

                    9.4%

                    57.1%

                  70.6%

               23.1%

 

 

(iii)    Credit Risk

 

Financial instruments which potentially subject us to concentrations of credit risk consist principally of cash and trade accounts receivable. We place our cash with high credit quality financial institutions in the United States and the PRC. At October 31, 2014, we had $875,666 on deposit in the PRC, where there is no equivalent of federal deposit insurance as in the United States. As a result, cash held in PRC financial institutions is not insured. We have not experienced any losses in such accounts through October 31, 2014.

 

Almost all of our sales are credit sales which are primarily to customers whose ability to pay is dependent upon the industry economics prevailing in these areas; however, we believe that the concentration of credit risk with respect to trade accounts receivable is limited due to generally short payment terms. We also perform ongoing credit evaluations of our customers to help further reduce potential credit risk.